|
|
The role of microglia in the development of white matter damage |
XU Manman CHAO Bin CUI Hanming PAN Juhua ZHANG Qiuyan HUANG Shijing#br#
Research and Development Center of Traditional Chinese Medicine, Guang′anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China |
|
|
Abstract Microglia is widely distributed in the central nervous system and is the inherent immune cells. The nerve inflammation mediated by microglia is an important factor that cause white matter damage. More and more evidences show that the activation pathways of microglia in different white matter damage diseases are different, which is the basis of their complex role in the central nervous system. The typical manifestation of white matter damage is demyelination, which is a common pathological stage in multiple diseases including multiple sclerosis, Alzheimer′s disease, vascular cognitive impairment and dementia. In this article, the medical mechanism for microglia playing biological role through different activation pathways under various disease types and different brain regions is discussed. In addition, microglia can play a biphasic role in brain white matter damage, such as proinflammatory and immunomodulatory effects, therefore further research on these microglial subtypes may lead to new treatments that promote the repair of white matter damage.
|
|
|
|
|
[1] Wake H,Moorhouse AJ,Miyamoto A,et al. Microglia:actively surveying and shaping neuronal circuit structure and function [J]. Trends Neurosci,2013,36(4):209-217.
[2] Arcuri C,Mecca C,Bianchi R,et al. The Pathophysiological Role of Microglia in Dynamic Surveillance,Phagocytosis and Structural Remodeling of the Developing CNS [J]. Front Mol Neurosci,2017,10:191.
[3] Prinz M,Priller J,Sisodia SS,et al. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration [J]. Nat Neurosci,2011,14(10):1227-1235.
[4] Sampaio-Baptista C,Johansen-Berg H. White Matter Plasticity in the Adult Brain [J]. Neuron,2017,96(6):1239-1251.
[5] Wu GF,Alvarez E. The Immunopathophysiology of Multiple Sclerosis [J]. Neurol Clin,2011,29(2):257-278.
[6] Jang H,Kwon H,Yang JJ,et al. Correlations between Gray Matter and White Matter Degeneration in Pure Alzheimer′s Disease,Pure Subcortical Vascular Dementia,and Mixed Dementia [J]. Sci Rep,2017,7(1):9541.
[7] Haber M,James J,Kim J,et al. Minocycline plus N-acteylcysteine induces remyelination,synergistically protects oligodendrocytes and modifies neuroinflammation in a rat model of mild traumatic brain injury [J]. J Cereb Blood Flow Metab,2018,38(8):1312-1326.
[8] Rosenberg GA,Prestopnik J,Knoefel J,et al. A Multimodal Approach to Stratification of Patients with Dementia:Selection of Mixed Dementia Patients Prior to Autopsy [J]. Brain Sci,2019,9(8):187.
[9] Bellani M,Boschello F,Delvecchio G,et al. DTI and myelin plasticity in bipolar disorder:integrating neuroimaging and neuropathological findings [J]. Front Psychiatry,2016,7:21.
[10] Lee J,Hamanaka G,Lo EH,et al. Heterogeneity of microglia and their differential roles in white matter pathology [J]. CNS Neurosci Ther,2019,25(12):1290-1298.
[11] Ponomarev ED,Shriver LP,Maresz K,et al. Microglial cell activation and proliferation precedes the onset of CNS autoimmunity [J]. J Neurosci Res,2005,81(3):374-389.
[12] Ihara M,Tomimoto H,Kinoshita M,et al. Chronic Cerebral Hypoperfusion Induces MMP-2 but not MMP-9 Expression in the Microglia and Vascular Endothelium of White Matter [J]. J Cereb Blood Flow Metab,2001,21(7):828-834.
[13] Ma J,Bo SH,Lu XT,et al. Protective effects of carnosine on white matter damage induced by chronic cerebral hypoperfusion [J]. Neural Regen Res,2016,11(9):1438.
[14] Sch?觟nrock LM,Kuhlmann T,Adler S,et al. Identification of glial cell proliferation in early multiple sclerosis lesions [J]. Neuropathol Appl Neurobiol,1998,24(4):320-330.
[15] Locatelli G,Theodorou D,Kendirli A,et al. Mononuclear phagocytes locally specify and adapt their phenotype in a multiple sclerosis model [J]. Nat Neurosci,2018,21(9):1196.
[16] Simpson J,Fernando M,Clark L,et al. White matter lesions in an unselected cohort of the elderly:astrocytic,microglial and oligodendrocyte precursor cell responses [J]. Neuropathol Appl Neurobiol,2007,33(4):410-419.
[17] Hammond TR,Dufort C,Dissing-Olesen L,et al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes [J]. Immunity,2019,50(1):253-271.e6.
[18] Leitner DF,Todorich B,Zhang X,et al. Semaphorin4A is cytotoxic to oligodendrocytes and is elevated in microglia and multiple sclerosis [J]. ASN Neuro,2015,7(3):1759091415587502.
[19] Pasquini L,Calatayud C,Una AB,et al. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia [J]. Neurochem Res,2007,32(2):279-292.
[20] Merrill JE,Ignarro LJ,Sherman MP,et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide [J]. J Immunol,1993,151(4):2132-2141.
[21] Olah M,Amor S,Brouwer N,et al. Identification of a microglia phenotype supportive of remyelination [J]. Glia,2012,60(2):306-321.
[22] Dai X,Chen J,Xu F,et al. TGFα preserves oligodendrocyte lineage cells and improves white matter integrity after cerebral ischemia [J]. J Cereb Blood Flow Metab,2020,40(3):639-655.
[23] Yuen TJ,Johnson KR,Miron VE,et al. Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination [J]. Brain,2013, 136(4):1035-1047.
[24] Lloyd AF,Miron VE. The pro-remyelination properties of microglia in the central nervous system [J]. Nat Rev Neurol,2019,15(8):447-458.
[25] Samanani S,Mishra M,Silva C,et al. Screening for inhibitors of microglia to reduce neuroinflammation [J]. CNS Neurol Disord Drug Targets,2013,12(6):741-749.
[26] Liu LQ,Liu XR,Zhao JY,et al. Brain-selective mild hypothermia promotes long-term white matter integrity after ischemic stroke in mice [J]. CNS Neurosci Ther,2018,24(12):1275-1285.
[27] Li Q,Wan J,Lan X,et al. Neuroprotection of brain-permeable iron chelator VK-28 against intracerebral hemorrhage in mice [J]. J Cereb Blood Flow Metab,2017,37(9):3110-3123.
[28] Fowler JH,Mcqueen J,Holland PR,et al. Dimethyl fumarate improves white matter function following severe hypoperfusion:Involvement of microglia/macrophages and inflammatory mediators [J]. J Cereb Blood Flow Metab,2018,38(8):1354-1370. |
|
|
|